The federal government is siding with a whistleblower who is suing Pfizer and a subsidiary, accusing them of illegally marketing the epilepsy drug Neurontin and offering lavish kickbacks to doctors. The case concerns "off-label" uses of Neurontin -- prescribing the drug for uses that the FDA has not officially approved.
May 29, 2003 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Presented by BigVoodoo
This conference brings together the industry's most influential & knowledgeable real estate executives from the net lease sector.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania with their dedication to law.
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
Prestigious mid-size NYC law firm seeks a highly motivated self-starter with four to six years' experience in general corporate, mergers and...
An international sports company that holds events worldwide is seeking a corporate counsel with 5-9 years of sophisticated corporate transac...
Our client, a boutique litigation firm established by former BigLaw partners, is seeking a junior associate with 1+ years of litigation expe...
MARTIN, CLEARWATER & BELL LLP COUNSELORS AT LAW IN MEMORY OF FRANCIS PETER BENSEL
GILL & CHAMAS Congratulations to our partner and friend,DAVID H. LANDE, ESQ on his appointment to Judge in the Division of Workers Compensation.
